Figure 3.

Effects of Oryza sativa L. cv. BB3CMU and BB4CMU extracts (RBO, 0.25 mg/mL; DFRB, 0.50 mg/mL; H, 0.10 mg/mL) on mRNA expression of (A) SRD5A1; (B) SRD5A2; (C) SRD5A3 in DU-145 prostate cancer cells after 24 h of treatment. Finasteride and dutasteride (0.10 mg/mL) were used as standard controls. Different letters within each treatment indicate significant differences (p < 0.05).